Wiiliam A. Boeger
Fondateur chez Chronix Biomedical, Inc.
Profil
Wiiliam A.
Boeger is the founder who starts Chronix Biomedical, Inc. in 1997, where he currently serves as Director & Director-Business Development.
He was previously Chairman & Chief Executive Officer at Calypte Biomedical Corp.
and held positions as Faculty at Dartmouth College and Principal at Harvard Medical School.
Boeger holds an MBA from Harvard University and an undergraduate degree from Williams College.
Postes actifs de Wiiliam A. Boeger
Sociétés | Poste | Début |
---|---|---|
Chronix Biomedical, Inc.
Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA. | Fondateur | 01/01/1997 |
Anciens postes connus de Wiiliam A. Boeger
Sociétés | Poste | Fin |
---|---|---|
Harvard Medical School | Corporate Officer/Principal | - |
Dartmouth College | Corporate Officer/Principal | - |
CALYPTE BIOMEDICAL CORPORATION | Président | - |
Formation de Wiiliam A. Boeger
Williams College | Undergraduate Degree |
Harvard University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Chronix Biomedical, Inc.
Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA. | Health Technology |
Calypte Biomedical Corp.
Calypte Biomedical Corp. Medical SpecialtiesHealth Technology Calypte Biomedical Corp. develops, manufactures and distributes vitro testing products, which improves the diagnosis of Human Immunodeficiency Virus infection, sexually transmitted diseases and other chronic diseases. The company's product line includes both point-of-case rapid tests and the BED incidence test. Calypte Biomedical was founded in 1988 and is headquartered in Portland, OR. | Health Technology |